Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable/Metastatic Colorectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05103020
What this trial is testing

Phase II Study Comparing Conversion Rate to Surgery With Hepatic Arterial Infusion Chemotherapy to Systemic Chemotherapy in Patients With Non Resectable Liver-only Colorectal Metastases

Who this might be right for
Metastatic Colorectal Cancer
Yonsei University 100
Testing effectiveness (Phase 2)Ended earlyNCT06332079
What this trial is testing

Holmium-166 TARE in Liver Limited Unresectable Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer Metastatic
Gruppo Oncologico del Nord-Ovest 4
Not applicableLooking for participantsNCT05248581
What this trial is testing

Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases

Who this might be right for
Colorectal Cancer Metastatic
University of Rochester 25
Testing effectiveness (Phase 2)Study completedNCT04109924
What this trial is testing

TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study

Who this might be right for
Advanced Colorectal CarcinomaMetastatic Colon AdenocarcinomaMetastatic Rectal Adenocarcinoma+24 more
Roswell Park Cancer Institute 42
Testing effectiveness (Phase 2)Study completedNCT01110941
What this trial is testing

Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in China

Who this might be right for
Colorectal Cancer
Shen Lin 20
Testing effectiveness (Phase 2)Ended earlyNCT03592641
What this trial is testing

Savolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal Cancer

Who this might be right for
Colorectal CarcinomaMetastatic Colon AdenocarcinomaMetastatic Rectal Adenocarcinoma+18 more
National Cancer Institute (NCI) 5
Early research (Phase 1)Ended earlyNCT01302405
What this trial is testing

Safety and Efficacy Study of PRI-724 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Prism Pharma Co., Ltd. 23
Testing effectiveness (Phase 2)Looking for participantsNCT06980532
What this trial is testing

Glumetinib Combined With Fruquintinib in the Treatment of MET Amplification or Protein Overexpression in Third-Line Unresectable Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Liu Huang 42
Testing effectiveness (Phase 2)Looking for participantsNCT05959356
What this trial is testing

Cetuximab and Envafolimab Plus mFOLFOXIRI as First-line Treatment for RAS/BRAF Wild-type, MSS, Unresectable Left-side Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Sun Yat-sen University 198
Testing effectiveness (Phase 2)Looking for participantsNCT06934538
What this trial is testing

First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer

Who this might be right for
Unresectable Metastatic Colorectal CancerUnresectable Locally Advanced Colorectal Cancer
Brenus Pharma 90
Large-scale testing (Phase 3)Active Not RecruitingNCT03635021
What this trial is testing

Study to Evaluate the Efficacy of FOLFOX + Panitumumab Followed by FOLFIRI + Bevacizumab (Sequence 1) Versus FOLFOX + Bevacizumab Followed by FOLFIRI + Panitumumab (Sequence 2) in Untreated Patients With Wild-type RAS Metastatic, Primary Left-sided, Unresectable Colorectal Cancer

Who this might be right for
Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 419
Testing effectiveness (Phase 2)UnknownNCT05406206
What this trial is testing

Hepatic Arterial Infusion Chemotherapy With Fruquintinib for Colorectal Cancer Liver Metastases As Third-line Therapy

Who this might be right for
Advanced Colorectal CarcinomaLiver Metastasis Colon Cancer
Peking University Cancer Hospital & Institute 27
Testing effectiveness (Phase 2)Study completedNCT03493061
What this trial is testing

Systemic Chemotherapy With CPT-11 Plus HAI (FUDR+L-OHP) in Patients With Initially Unresectable CRCLM

Who this might be right for
Colo-rectal CancerLiver Metastases
Sun Yat-sen University 60
Testing effectiveness (Phase 2)WithdrawnNCT00346099
What this trial is testing

Study of Panitumumab Given First With Capecitabine and Oxaliplatin (CAPOX) and Then With Capecitabine and Radiation of the Pelvis for Treatment of Patients With Rectal Cancers That May or May Not Have Spread Beyond the Rectum

Who this might be right for
Rectal CancerNeoplasm Metastasis
NSABP Foundation Inc
Early research (Phase 1)Looking for participantsNCT07094204
What this trial is testing

Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Who this might be right for
Solid TumorNon-Small-Cell Lung CancerPancreatic Ductal Adenocarcinoma+1 more
Astellas Pharma Inc 364
Testing effectiveness (Phase 2)Ended earlyNCT02842580
What this trial is testing

De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Federation Francophone de Cancerologie Digestive 21
Testing effectiveness (Phase 2)Study completedNCT00089401
What this trial is testing

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
National Institutes of Health Clinical Center (CC) 8
Not applicableStudy completedNCT00253383
What this trial is testing

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

Who this might be right for
Cancer
Dartmouth-Hitchcock Medical Center 329
Not applicableStudy completedNCT02282722
What this trial is testing

Improving Informed Consent for Palliative Chemotherapy

Who this might be right for
Metastatic Colorectal CancerMetastatic Pancreatic CancerUnresectable Pancreatic Cancer
Dana-Farber Cancer Institute 216
Testing effectiveness (Phase 2)UnknownNCT05797883
What this trial is testing

FOLFOX/FOLFIRI Containing Levofolinic Acid (Zuoyu ®) in the Treatment of Unresectable or Metastatic Colorectal Cancer

Who this might be right for
Unresectable or Metastatic Colorectal Cancer
China Medical University, China 30
Next Page